The validity and value of cell therapy safety protocol inventions (T 1555/23) By Dr Rose Hughes at Friday, February 27, 2026 cell therapy epo ip strategy manufacturing IP patents PatKat pharma ip Rose Hughes +
Never Too Late: If you missed the IPKat last week! By Wissam Bentazar at Friday, February 27, 2026 #NeverTooLate #UPC Artificial Intelligence Wissam Bentazar +
[Guest Post] Ceci n’est pas du Gruyère: Swiss origin claims and how to deal with them By Marcel Pemsel at Friday, February 27, 2026 appellations of origin Federica Pezza geographic indications Swissness trade marks +
[Guest post] Retromark Volume XVII: the last six months in trade marks By Eleonora Rosati at Thursday, February 26, 2026 Darren Meale; trade marks; Retromark +
The never-ending story of Brexit – The Final Chapter By Marcel Pemsel at Wednesday, February 25, 2026 Ape Tees Brexit C-337/22 P CJEU Marcel Pemsel Nowhere trade marks +
Tuesday Tiddlywinks By Eleonora Rosati at Tuesday, February 24, 2026 Eleonora Rosati events Miscellany +
[UPCKat] 2025 UPC cases and outcomes: What do the numbers say? By Annsley Merelle Ward at Tuesday, February 24, 2026 #IPKat AmeriKat infringement revocation statistics UPCA UPCKat +
Accounts of profits & threats: Luxe World v Touch of Vogue By Oliver Fairhurst at Monday, February 23, 2026 design rights IPEC Luxe World v Tough of Vogue Oliver Fairhurst unjustified threats +
Saturday Sundries By Dr Claire Gregg at Saturday, February 21, 2026 Claire Gregg IP News Miscellany OzKat +
Never Too Late: If you missed the IPKat last week! By Simone Lorenzi at Friday, February 20, 2026 #NeverTooLate copyright event report IP patents plant varieties Simone Lorenzi trade marks +
Skating between human magic and machine, the fragile fate of generative AI ‘works’ By Georgia Jenkins at Friday, February 20, 2026 AI AI generated creations Artificial Intelligence author's own intellectual creation copyright work cultural production Georgia Jenkins German copyright law human creativity logos originality +
[Guest Post] What the Inari vs. Corteva case really tells us about enablement of plant inventions By Jocelyn Bosse at Saturday, February 14, 2026 enablement genetic modification patents plant varieties +
Never Too Late: If you missed the IPKat last week! By Kliment Markov at Saturday, February 14, 2026 #NeverTooLate AI copyright designs Kliment Markov patents plant varieties +
H 15 - Too unusual to be used as a trade mark? By Marcel Pemsel at Friday, February 13, 2026 genuine use German Supreme Court H 15 I ZR 30/25 independent distinctive role Marcel Pemsel trade marks +
Friday Fantasies By Georgia Jenkins at Friday, February 13, 2026 call for papers events Georgia Jenkins IP News Miscellany opportunities +
Annual Conference on EU Law in the Pharmaceutical Sector returns with IPKat readers’ discount By Eleonora Rosati at Thursday, February 12, 2026 events IPKat readers pharma +
Rethinking creative fairness under the UK’s new automated decision-making rules By Georgia Jenkins at Thursday, February 12, 2026 ADM automated decision-making creative industries digital platforms Digital Services Act GDPR Georgia Jenkins performance data personal data post-brexit recommendation systems +